Clinical trial
Rationale and Design of a Multicenter Randomized Trial of Levosimendan to Reduce Low Cardiac Output Syndrome in Low Ejection Fraction (≤ 35%) Cardiac Surgery Patients. Spanish Randomized Clinical Trial on Levosimendan (SPARTANS Study)
NCT04179604 is registered in ClinicalTrials.gov with María de los Ángeles Tena Pajuelo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rationale and Design of a Multicenter Randomized Trial of Levosimendan to Reduce Low Cardiac Output Syndrome in Low Ejection Fraction (≤ 35%) Cardiac Surgery Patients. Spanish Randomized Clinical Trial on Levosimendan (SPARTANS Study)
- Lead sponsor
- María de los Ángeles Tena Pajuelo
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- June 17, 2020
- Completion date
- December 31, 2022
- Enrollment
- 300 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.